Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Urologia Internationalis|June 28, 2018
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate CancerChristopher Darr, Ulrich Krafft, Boris Hadaschik, et al.
Diagnostics (Basel, Switzerland)|January 5, 2021
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer PatientsTibor Szarvas, Michèle J Hoffmann, Csilla Olah, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 19, 2013
Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CTPal Bata, David Laszlo Tarnoki, Adam Domonkos Tarnoki, et al.
Cancer Medicine|October 7, 2022
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerCsilla Olah, Henning Reis, Michèle J Hoffmann, et al.
The Journal of Pathology. Clinical Research|January 16, 2025
Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapyCsilla Olah, Oleksandr Shmorhun, Gilbert Georg Klamminger, et al.
Urologic Oncology|March 5, 2020
Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomyKeiichiro Mori, Florian Janisch, Hadi Mostafaei, et al.
Central European Journal of Urology|January 27, 2022
Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysisAbdulmajeed Aydh, Reza Sari Motlagh, Mishari Alshyarba, et al.
Pageof 4